PCN89 A Cost-Effectiveness Analysis of Atezolizumab in Combination with Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small Cell Lung Cancer
Autor: | R. Belleli, H. Celik, A.Y. Castro, F. Lourenço, P. Orfanos, B. Pinheiro, Margarida Borges, M. Cardoso, L. Silva Miguel |
---|---|
Rok vydání: | 2020 |
Předmět: |
Oncology
medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Cost-effectiveness analysis Carboplatin chemistry.chemical_compound chemistry Atezolizumab Internal medicine medicine In patient business Extensive-stage small cell lung cancer Etoposide medicine.drug |
Zdroj: | Value in Health. 23:S437-S438 |
ISSN: | 1098-3015 |
Databáze: | OpenAIRE |
Externí odkaz: |